Patent details
300990 Product Name: Brigatinib, dan wel een farmaceutisch aanvaardbaar zout daarvan
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300990
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP2300013
- Status:
- SPC granted but not yet in force
- Application number:
- 300990
- Procedural language:
- Dutch
- First Applicant Residence Country:
- United States of America (US)
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1264
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 26/11/2018
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 17/05/2019
- First Marketing Authorization date:
- 26/11/2018
- Grant date:
- 11/07/2019
- Activation date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 22/05/2019
- SPC/SPC Extension Expiration Date:
- 25/11/2033
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 05/11/2021
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan (JP)
Historical Applicant/holder
- From:
- 17/05/2019
- To:
- 05/11/2021
- Name:
- ARIAD PHARMACEUTICALS, INC.
- Address:
- 40 Landsdowne Street, 02139, Cambridge, MA , United States of America (US)
Agent
- Name:
- ir. H.A. Witmans c.s.
- From:
- 17/05/2019
- Address:
- V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Journal edition number:
- 49/21
- Publication date:
- 08/12/2021
- Description:
- Changes in the Netherlands Patent Register
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 29/19
- Publication date:
- 17/07/2019
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 22/19
- Publication date:
- 29/05/2019
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202102373B
- Date Registered:
- 05/11/2021
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- Baker & McKenzie Amsterdam N.V.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan (JP)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 31/05/2029
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 1600 Euro
- Last Annual Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 10/02/2025 | Incoming Correspondence Paper | Accompanying letter incoming document | 62 | /4/3/4/5/1/0800415434/docs/300990_10_incomingcorrespondencepaper20250210021830390.pdf | ||
| 11/07/2019 | SPC Documents | Certificate SPC | 1 | /4/3/4/5/1/0800415434/docs/300990_4_supplprotectioncertificate20190712091411450.pdf | ||
| 11/07/2019 | Outgoing Correspondence | Decision grant | 1 | /4/3/4/5/1/0800415434/docs/300990_8_outgoingcorrespondence20190712091411377.pdf | ||
| 24/05/2019 | Outgoing Correspondence | Confirmation receipt request | 1 | /4/3/4/5/1/0800415434/docs/300990_6_275542l174.pdf | ||
| 17/05/2019 | SPC Documents | Annex SPC | 3 | /4/3/4/5/1/0800415434/docs/300990_0_supplprotectioncertificate20190522022110814.pdf | ||
| 17/05/2019 | SPC Documents | Annex SPC | 27 | /4/3/4/5/1/0800415434/docs/300990_1_supplprotectioncertificate20190522022110884.pdf | ||
| 17/05/2019 | SPC Documents | Marketing Authorization SPC | 3 | /4/3/4/5/1/0800415434/docs/300990_2_supplprotectioncertificate20190522022110646.pdf | ||
| 17/05/2019 | SPC Documents | Summary of the characteristics of the product | 24 | /4/3/4/5/1/0800415434/docs/300990_3_supplprotectioncertificate20190522022110724.pdf | ||
| 17/05/2019 | SPC Documents | Accompanying letter SPC | 2 | /4/3/4/5/1/0800415434/docs/300990_5_supplprotectioncertificate20210122020343212.pdf | ||
| 17/05/2019 | Application Form | First filed application form | 3 | /4/3/4/5/1/0800415434/docs/300990_7_applicationform20190522022110397.pdf | ||
| 17/05/2019 | SPC Documents | Annex SPC | 1 | /4/3/4/5/1/0800415434/docs/300990_9_supplprotectioncertificate20190522022110956.pdf |